Аллергический ринит: современная оценка медико-социальных аспектов и способов лечения интраназальные кортикостероиды в лечении ринитов
https://doi.org/10.21518/2079-701X-2018-17-187-191
Аннотация
В статье представлены вопросы эпидемиологии, патогенеза и лечения аллергического ринита. Рассмотрены различные виды неаллергического ринита, взаимосвязь аллергического ринита и полипозного риносинусита, эозинофильного неаллергического ринита, медикаментозного ринита. Подробно рассмотрена ведущая роль топических глюкокортикостероидов в терапии ринита, в том числе неаллергического.
Об авторе
С. В. Царев
ФГБУ «Государственный научный центр «Институт иммунологии» Федерального медико-биологического агентства России
Россия
Россия
Царев Сергей Владимирович – доктор медицинских наук, врач поликлинического отделения №1
Москва
Список литературы
1. http: //www.worldallergy.org/wao-white-bookonallergy
2. Pols DHJ, Wartna JB, Moed H, van Alphen EI, Bohnen AM, Bindels PJ. Atopic dermatitis, asthma and allergic rhinitis in general practice and the open population: a systematic review. Scand J Prim Health Care, 2016, 34: 143-150.
3. Hill DA, Grundmeier RW, Ram G, Spergel JM. The epidemiologic characteristics of healthcare provider-diagnosed eczema, asthma, allergic rhinitis, and food allergy in children: retrospective cohort study. BMC Pediatr, 2016, 16: 133.
4. Kim JL, Brisman JAl, Aberg MA, Forslund HB, Winkvist A, Toren K. Trends in the prevalence of asthma, rhinitis and eczema in 15 year old adolescents over an 8 year period. Respir Med, 2014, 108: 701-708.
5. Wood RA, Sicherer SH, Vickery BP, Jones SM, Liu AH, Fleischer DM еt al. The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol, 2013, 131: 805-812.
6. Hatzler L, Panetta V, Lau S, Wagner P, Bergmann RL, Illi S et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol, 2012, 130: 894-901.
7. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A еt al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organiza tion, GA(2)LEN and AllerGen). Allergy, 2008, 63: 8-160.
8. Богова А.В., Ильина Н.И., Лусс Л.В. Тенденции в изучении эпидемиологии аллергических заболеваний в России за последние 10 лет. Российский аллергологический журнал, 2008, 6: 3-14.
9. Lindner M. When allergies attack. Fortune, 2010, 162(2): 14.
10. Cardell L-O, Olsson P, Andersson M, Welin KO, Svensson J, Tennvall GR et al. TOTALL: high cost of allergic rhinitis – a national Swedish population-based questionnaire study. NPJ Prim Care Respir Med, 2016, 26: 15082.
11. Linneberg A, Dam Petersen K, Hahn-Pedersen J, Hammerby E, Serup-Hansen N, Boxall N. Burden of allergic respiratory disease: a systematic review. Clin Mol Allergy, 2016, 14: 12.
12. Canonica GW, Mullol J, Pradalier A, Didier A. Patient perceptions of allergic rhinitis and quality of life: findings from a survey conducted in Europe and the United States. World Allergy Organ J, 2008, 1: 138-144.
13. Meltzer EO, Gross GN, Katial R, Storms, WW. Allergic rhinitis substantially impacts patient quality of life: findings from the Nasal Allergy Survey Assessing Limitations. J Fam Pract, 2012, 61: 5-10.
14. Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines – 2016 revision. J Allergy Clin Immunol, 2017, 140: 950-958.
15. Poddighe D, Gelardi M, Licari A, del Giudice M M, Marseglia GL. Non-allergic rhinitis in children: Epidemiological aspects, pathological features, diagnostic methodology and clinical management. World J Methodol, 2016, 6: 200–213.
16. Vandenplas O, Vinnikov D, Blanc PD, Agache I, Bachert C, Bewick M et al. Impact of Rhinitis on Work Productivity: A Systematic Review. J Allergy Clin Immunol Pract, 2017, 6: 1274-1286.
17. Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med, 2000, 162: 1391-1396.
18. Schatz M, Zeiger RS. Telephone-based environmental control interventions in asthmatic patients: what are patients willing to do? Ann Allergy Asthma Immunol, 2012, 109: 99-102.
19. Braido F, Arcadipane F, Marugo F, Hayashi M, Pawankar R. Allergic rhinitis: current options and future perspectives. Curr Opin Allergy Clin Immunol, 2014, 2: 168-176.
20. Suzaki H. Action mechanisms of glucocorticoids on rhinosinusitis. Asian Rhinology Journal, 2013, 1: 3-13.
21. Johnson M. Development of fluticasone propionate and comparison with other inhaled corticosteroids. J Allergy Clin Immunol, 1998, 101: 434-439.
22. Smith CL, Kreutner W. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids. Arzneimittelforschung, 1998, 48: 956-960.
23. Demoly P. Safety of intranasal corticosteroids in acute rhinosinusitis. Am J Otolaryngol, 2008, 29: 403-413.
24. Canonica GW, Compalati E. Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies. Clin Exp Immunol, 2009, 158(3): 260-271.
25. Kaliner MA. Nonallergic rhinopathy (formerly known as vasomotor rhinitis). Immunol Allergy Clin North Am, 2011, 31: 441-455.
26. Kern R. Allergy: a constant factor in the etiology of so-called mucous nasal polyps. J Allergy, 1993, 4: 483.
27. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol. Suppl, 2012, 50: 1-298.
28. Suzaki H. Action mechanisms of glucocorticoids on rhinosinusitis. Asian Rhinology Journal, 2013, 1: 3-13.
29. Potter PC, Pawankar R. Indications, efficacy, and safety of intranasal corticosteriods in rhinosinusitis. World Allergy Organ J, 2012, 5: 14-17.
30. Ahmadiafshar A, Farjd HR, Moezzi F, Mousavinasab N. Nasal polyposis in patients with asthma and allergic rhinitis. J Laryngol Otol, 2012, 126: 780-783.
31. Польнер С.А., Козаренко Е.А., Шевцов Е.А. Целесообразность и место риносептопластики в комплексном лечении аллергического ринита и бронхиальной астмы. Цитокины и воспаление, 2012, 12(3): 130-132.
32. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy, 2007, 62: 17–25.
33. Hellings PW, Klimek L, Cingi C, Agache I, Akdis C, Bachert C et al. Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology. Allergy, 2017, 72: 1657-1665.
34. Saco TV, Pepper A, Casale TB. Uses of biologics in allergic diseases: What to choose and when. Ann Allergy Asthma Immunol, 2018, 120: 357-366.
Рецензия
Для цитирования:
Царев СВ. Аллергический ринит: современная оценка медико-социальных аспектов и способов лечения интраназальные кортикостероиды в лечении ринитов. Медицинский Совет. 2018;(17):187-192. https://doi.org/10.21518/2079-701X-2018-17-187-191
For citation:
Tsarev SV. Allergic rhinitis: current assessment of medical and social aspects and methods of treatment. intranasal corticosteroids in the treatment of rhinitis. Meditsinskiy sovet = Medical Council. 2018;(17):187-192. (In Russ.) https://doi.org/10.21518/2079-701X-2018-17-187-191
Просмотров:
933
Послать статью по эл. почте 